Celgene to Sell Otezla for $13.4B
The company agreed to divest the psoriasis treatment as part of its merger with Bristol-Myers Squibb.
Bristol-Myers to Buy Big Pharma Rival Celgene
The $74 billion deal could create the fourth-largest U.S. pharma firm, with a portfolio that includes nine blockbuster drugs.
CFOs on the Move: Week Ending June 8
Ellie Mae, Lowe's, Newell Brands, CPI Card Group, Advance Publications, The Andersons, Fitbit, Hayward Industries, Owens & Minor, Celgene